Pradofloxacin

Last updated

Pradofloxacin
Pradofloxacin.svg
Clinical data
Trade names Veraflox, Pradalex
License data
Routes of
administration
By mouth, intramuscular, subcutaneous
ATCvet code
Legal status
Legal status
Identifiers
  • 8-Cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-(4.3.0)nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard 100.169.611 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C21H21FN4O3
Molar mass 396.422 g·mol−1
3D model (JSmol)
  • O=C(O)C1=CN(C2CC2)c3c(C1=O)cc(F)c(c3C#N)N4C[C@H]5NCCC[C@H]5C4
  • InChI=1S/C21H21FN4O3/c22-16-6-13-18(26(12-3-4-12)9-15(20(13)27)21(28)29)14(7-23)19(16)25-8-11-2-1-5-24-17(11)10-25/h6,9,11-12,17,24H,1-5,8,10H2,(H,28,29)/t11-,17+/m0/s1 X mark.svgN
  • Key:LZLXHGFNOWILIY-APPDUMDISA-N X mark.svgN
 X mark.svgNYes check.svgY  (what is this?)    (verify)

Pradofloxacin, sold under the brand name Veraflox among others, is a third-generation enhanced spectrum veterinary antibiotic of the fluoroquinolone class. [5] It was developed by Elanco Animal Health GmbH and received approval from the European Commission in April 2011, for prescription-only use in veterinary medicine for the treatment of bacterial infections in dogs and cats. [6] [7]

Contents

Medical uses

Dogs

In the European Union, pradofloxacin is indicated for the treatment of: [8]

Cats

In the European Union, pradofloxacin is indicated for the treatment of: [8]

Cattle and swine

In the United States, pradofloxacin is indicated for certain respiratory diseases in cattle and swine. [5] It is approved for certain ages and classes of cattle for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica , Pasteurella multocida , Histophilus somni , and Mycoplasma bovis . [5] It may only be prescribed for cattle intended for slaughter and cattle intended for breeding that are less than one year of age; it is not for use in cattle intended for breeding one year of age and older, beef calves less than two months of age, dairy calves, and veal calves. [5] It is approved for use in swine for the treatment of swine respiratory disease (SRD) associated with Bordetella bronchiseptica , Glaesserella (Haemophilus) parasuis , Pasteurella multocida , Streptococcus suis , and Mycoplasma hyopneumoniae . [5] It may only be prescribed for weaned swine intended for slaughter; it is not for use in swine intended for breeding or nursing piglets. [5]

Mechanism of action

The primary mode of action of fluoroquinolones involves interaction with enzymes essential for major DNA functions such as replication, transcription and recombination. The primary targets for pradofloxacin are the bacterial DNA gyrase and topoisomerase IV enzymes. Reversible association between pradofloxacin and DNA gyrase or DNA topoisomerase IV in the target bacteria results in inhibition of these enzymes and rapid death of the bacterial cell. The rapidity and extent of bacterial killing are directly proportional to the drug concentration. [8]

As a result, pradofloxacin is active against a wide range of Gram-positive and Gram-negative bacteria including anaerobic bacteria. [8]

History

Pradofloxacin was first discovered by chemists at Bayer in 1994 and patented in 1998. The name pradofloxacin was issued in December 2000 by the World Health Organization. Following submission for marketing authorisation to the European Medicines Agency (EMA) in 2004, the application was refused in 2006, [10] prompting further studies.

Having reviewed the additional studies, the EMA Committee for Medicinal Products for Veterinary Use (CVMP) recommended granting marketing authorisation of pradofloxacin by consensus in February 2011. [11] Marketing authorisation of pradofloxacin was granted by the European Commission in April 2011. [6]

Related Research Articles

<span class="mw-page-title-main">Amoxicillin/clavulanic acid</span> Combination antibiotic medication

Amoxicillin/clavulanic acid, also known as co-amoxiclav or amox-clav, sold under the brand name Augmentin, among others, is an antibiotic medication used for the treatment of a number of bacterial infections. It is a combination consisting of amoxicillin, a β-lactam antibiotic, and potassium clavulanate, a β-lactamase inhibitor. It is specifically used for otitis media, streptococcal pharyngitis, pneumonia, cellulitis, urinary tract infections, and animal bites. It is taken by mouth or by injection into a vein.

<span class="mw-page-title-main">Ofloxacin</span> Antibiotic to treat bacterial infections

Ofloxacin is a quinolone antibiotic useful for the treatment of a number of bacterial infections. When taken by mouth or injection into a vein, these include pneumonia, cellulitis, urinary tract infections, prostatitis, plague, and certain types of infectious diarrhea. Other uses, along with other medications, include treating multidrug resistant tuberculosis. An eye drop may be used for a superficial bacterial infection of the eye and an ear drop may be used for otitis media when a hole in the ear drum is present.

<span class="mw-page-title-main">Norfloxacin</span> Chemical compound, antibiotic

Norfloxacin, sold under the brand name Noroxin among others, is an antibiotic that belongs to the class of fluoroquinolone antibiotics. It is used to treat urinary tract infections, gynecological infections, inflammation of the prostate gland, gonorrhea and bladder infection. Eye drops were approved for use in children older than one year of age.

<span class="mw-page-title-main">Marbofloxacin</span> Chemical compound

Marbofloxacin is a carboxylic acid derivative third generation fluoroquinolone antibiotic. It is used in veterinary medicine under the brand names Marbocyl, Forcyl, Marbo vet and Zeniquin. A formulation of marbofloxacin combined with clotrimazole and dexamethasone is available under the name Aurizon.

<span class="mw-page-title-main">Pefloxacin</span> Antibiotic

Pefloxacin is a quinolone antibiotic used to treat bacterial infections. Pefloxacin has not been approved for use in the United States.

<span class="mw-page-title-main">Florfenicol</span> Chemical compound

Florfenicol is a fluorinated synthetic analog of thiamphenicol, mainly used as a antibiotic in veterinary medicine.

<i>Pasteurella multocida</i> Species of bacterium

Pasteurella multocida is a Gram-negative, nonmotile, penicillin-sensitive coccobacillus of the family Pasteurellaceae. Strains of the species are currently classified into five serogroups based on capsular composition and 16 somatic serovars (1–16). P. multocida is the cause of a range of diseases in mammals and birds, including fowl cholera in poultry, atrophic rhinitis in pigs, and bovine hemorrhagic septicemia in cattle and buffalo. It can also cause a zoonotic infection in humans, which typically is a result of bites or scratches from domestic pets. Many mammals and birds harbor it as part of their normal respiratory microbiota.

<span class="mw-page-title-main">Cefquinome</span> Chemical compound

Cefquinome is a fourth-generation cephalosporin with pharmacological and antibacterial properties valuable in the treatment of coliform mastitis and other infections. It is only used in veterinary applications.

<span class="mw-page-title-main">Prulifloxacin</span> Chemical compound

Prulifloxacin is an older synthetic antibiotic of the fluoroquinolone class undergoing clinical trials prior to a possible NDA submission to the U.S. Food and Drug Administration (FDA). It is a prodrug which is metabolized in the body to the active compound ulifloxacin. It was developed over two decades ago by Nippon Shinyaku Co. and was patented in Japan in 1987 and in the United States in 1989.

<span class="mw-page-title-main">Tulathromycin</span> Cattle and pig antibiotic

Tulathromycin, sold under the brand name Draxxin among others, is a macrolide antibiotic used to treat bovine respiratory disease in cattle and swine respiratory disease in pigs.

<span class="mw-page-title-main">Difloxacin</span> Chemical compound

Difloxacin (INN), marketed under the trade name Dicural, is a second-generation, synthetic fluoroquinolone antibiotic used in veterinary medicine. It has broad-spectrum, concentration dependent, bactericidal activity; however, its efficacy is not as good as enrofloxacin or pradofloxacin.

<span class="mw-page-title-main">Tylosin</span> Chemical compound

Tylosin is a macrolide antibiotic and bacteriostatic feed additive used in veterinary medicine. It has a broad spectrum of activity against Gram-positive organisms and a limited range of Gram-negative organisms. It is found naturally as a fermentation product of Streptomyces fradiae.

<span class="mw-page-title-main">Quinolone antibiotic</span> Class of antibacterial drugs, subgroup of quinolones

Quinolone antibiotics constitute a large group of broad-spectrum bacteriocidals that share a bicyclic core structure related to the substance 4-quinolone. They are used in human and veterinary medicine to treat bacterial infections, as well as in animal husbandry, specifically poultry production.

Staphylococcus delphini is a Gram-positive, coagulase-positive member of the bacterial genus Staphylococcus consisting of single, paired, and clustered cocci. Strains of this species were originally isolated from aquarium-raised dolphins suffering from skin lesions.

Staphylococcus schleiferi is a Gram-positive, cocci-shaped bacterium of the family Staphylococcaceae. It is facultatively anaerobic, coagulase-variable, and can be readily cultured on blood agar where the bacterium tends to form opaque, non-pigmented colonies and beta (β) hemolysis. There exists two subspecies under the species S. schleiferi: Staphylococcus schleiferi subsp. schleiferi and Staphylococcus schleiferi subsp. coagulans.

Staphylococcus pseudintermedius is a gram-positive spherically shaped bacterium of the genus Staphylococcus found worldwide. It is primarily a pathogen for domestic animals, but has been known to affect humans as well. S. pseudintermedius is an opportunistic pathogen that secretes immune-modulating virulence factors, has many adhesion factors, and the potential to create biofilms, all of which help to determine the pathogenicity of the bacterium. Diagnoses of S. pseudintermedius have traditionally been made using cytology, plating, and biochemical tests. More recently, molecular technologies like MALDI-TOF, DNA hybridization and PCR have become preferred over biochemical tests for their more rapid and accurate identifications. This includes the identification and diagnosis of antibiotic resistant strains.

Bovine respiratory disease (BRD) is the most common and costly infectious disease affecting beef cattle in the world. It is a complex, bacterial or viral infection that causes pneumonia in calves which can be fatal. The infection is usually a sum of three codependent factors: stress, an underlying viral infection, and a new bacterial infection. The diagnosis of the disease is complex since there are multiple possible causes.

<span class="mw-page-title-main">Zoliflodacin</span> Chemical compound

Zoliflodacin is an experimental antibiotic that is being studied for the treatment of infection with Neisseria gonorrhoeae (gonorrhea). It has a novel mechanism of action which involves inhibition of bacterial type II topoisomerases. Zoliflodacin is being developed by Innoviva Specialty Therapeutics, and the drug has demonstrated clinical efficacy equivalent to ceftriaxone in Phase III clinical trials.

<span class="mw-page-title-main">Bovine respiratory syncytial virus</span> Respiratory virus of cattle

Bovine respiratory syncytial virus (BRSV) is pneumovirus closely related to human respiratory syncytial virus (RSV) that is a common cause of respiratory disease in cattle, particularly calves. It is a negative-sense, single-stranded RNA virus that replicates in the cytoplasm of the cell. Similarly to other single-stranded RNA viruses, the genome of BRSV has a high mutation rate, which results in great antigenetic variation. Thus, BRSV can be split into four different subgroups based on antigen expression.

<span class="mw-page-title-main">Tildipirosin</span> Medication

Tildipirosin, sold under the brand name Zuprevo is an antibiotic used in pigs and cattle.

References

  1. "Veraflox Product information". Health Canada . 19 May 2022. Retrieved 12 April 2024.
  2. "Veraflox- pradofloxacin suspension". DailyMed. 14 October 2022. Retrieved 12 April 2024.
  3. "Pradalex (pradofloxacin injection) Injectable Solution". New Animal Drug Application. U.S. Food and Drug Administration. NADA 141-550.
  4. "Veraflox EPAR". European Medicines Agency. 12 April 2011. Retrieved 12 April 2024.
  5. 1 2 3 4 5 6 "FDA Approves New Antimicrobial Drug for Cattle and Swine". U.S. Food and Drug Administration (FDA). 9 April 2024. Retrieved 12 April 2024.PD-icon.svg This article incorporates text from this source, which is in the public domain .
  6. 1 2 "Veraflox Product information". Union Register of veterinary medicinal products. Retrieved 20 June 2012.
  7. Sykes JE, Blondeau JM (August 2014). "Pradofloxacin: a novel veterinary fluoroquinolone for treatment of bacterial infections in cats". Veterinary Journal. 201 (2). London, England: 207–14. doi:10.1016/j.tvjl.2014.06.008. PMID   24997792.
  8. 1 2 3 4 "Veraflox Summary of Product Characteristics" (PDF). European Medicines Agency. April 2011. Archived from the original (PDF) on 2 February 2017. Retrieved 2 December 2011.
  9. "NOAH Compendium of Animal Medicines: Veraflox Tablets - Dosage and administration". Archived from the original on 28 April 2015. Retrieved 29 June 2015.
  10. "European Medicines Agency - Find medicine - Veraflox". European Medicines Agency. Archived from the original on 22 February 2014. Retrieved 20 June 2012.
  11. "European Medicines Agency - Find medicine - Veraflox". European Medicines Agency. Retrieved 20 June 2012.